Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan
about
Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis populationKidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis.Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patientsMineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational studyAssociation of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients.Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysisAnalysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patientsPrescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D studyMineral metabolic abnormalities and mortality in dialysis patients.Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.Chronic Kidney Disease-Mineral and Bone Disorder in Asia.Impact of Lanthanum Carbonate on Prognosis of Chronic Hemodialysis Patients: A Retrospective Cohort Study (Kawashima Study).Clinical significance of parathyroid intervention on CKD-MBD management.Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients.The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients.A Japanese approach for CKD-MBDSerum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients.Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.Calcification of the thoracic aorta determined by three-dimensional computed tomography predicts cardiovascular complications in patients undergoing hemodialysis.Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial.Association between Extreme Values of Markers of Chronic Kidney Disease: Mineral and Bone Disorder and 5-Year Mortality among Prevalent Hemodialysis Patients.Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients.Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan.Efficacy of oral powder compared with chewable tablets for lanthanum carbonate administration in hemodialysis patients.Higher dialysate calcium concentration is associated with incident myocardial infarction among diabetic patients with low bone turnover: a longitudinal study.Efficacy of continuous oral administration of lanthanum carbonate over 24 monthsStudy of prolonged administration of lanthanum carbonate in dialysis patients
P2860
Q30975803-DFF15A3B-A8B2-4E0E-B4F9-794A84244C6BQ33862710-83C4BE63-CC2E-4527-9651-5E242F5E8E92Q33878430-0B2A32D8-BB66-4E9C-B748-1EDC85E26AEDQ33881773-E3B090B9-3EDA-4BEB-B00B-8D1094B88398Q34545929-61DB5E72-490C-4269-8089-345186235AFFQ34672695-D5A58CA8-DA04-4B38-9F68-0FD879EEBDCAQ35030613-918B28C9-3519-4EB6-A7B9-FFB74F879BAFQ35189516-90A83513-D863-4B92-8247-11A4F7D34AAAQ35219236-9AF62126-09E5-4127-A8CD-1C32B46CA80DQ35391160-BA7A166C-86A6-4ACF-B543-039F66DE1F42Q35983513-FB26C7CF-02B4-4F24-9CC6-A086D7D76882Q36079391-ACEC9051-20D6-4D15-A79D-B669C9F00F0FQ36166690-3E6D8D3A-FDFB-40A9-89CE-117E94A20D7DQ36193436-B8CA300D-264D-4239-AE64-14A4501D7DE5Q36199558-88166F1F-B678-4C0B-8292-7EC30327CB03Q36994038-496A0DA7-0E13-4D9C-843B-77BF99DA13C0Q37807991-C0FE4E18-19F8-4950-9DD9-07E27C0FC61AQ38635767-9E40D045-1124-4F79-B1B4-7DCC086D9A0CQ38901641-9C3E77E0-ADA5-457E-9544-72BAE560949DQ40318270-5DD14AD9-7506-441C-B209-75599DB396D8Q41661620-4D780A04-A412-489B-B611-B61E751D6856Q41913376-2BBE90A1-B045-410D-B459-99DD52C0F85AQ42727652-18392275-DB3F-49E7-AF43-62AAD02E970FQ43405909-E70838E5-682A-481A-9CEC-EECA2D8C1AEBQ43427754-0E89E81B-4F2C-4809-B53D-04BF442956B5Q43692416-9F921113-8F0C-4006-BDC2-26FBB5E4C790Q44328455-4673C01D-A35B-4676-B514-935841A5606FQ50203254-3A16C16E-1A4C-49ED-8A2D-CCCFBD5D48B5Q51207887-41CCD7CC-2FBE-449A-96F9-C21B6950B39BQ51249822-A160F5B8-C973-4C38-AAB2-68B3BD480095Q51459155-E0C1BE97-C8AB-4892-AFBE-684EFA6A4F57Q54689850-FF439AA3-2F3F-42FF-95C1-6643E8856242Q55528210-D59C0E15-5C56-44C7-8CF2-59516D9EE552Q57217883-6571909C-B28C-43E8-8709-E4F2D74E6FCBQ57217888-F19C1E95-FF9C-49C4-A23B-445909526D39
P2860
Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan
description
scientific article published on 01 February 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2008
@uk
name
Effects of Serum Calcium, Phos ...... Hemodialysis Patients in Japan
@en
Effects of Serum Calcium, Phos ...... Hemodialysis Patients in Japan
@nl
type
label
Effects of Serum Calcium, Phos ...... Hemodialysis Patients in Japan
@en
Effects of Serum Calcium, Phos ...... Hemodialysis Patients in Japan
@nl
prefLabel
Effects of Serum Calcium, Phos ...... Hemodialysis Patients in Japan
@en
Effects of Serum Calcium, Phos ...... Hemodialysis Patients in Japan
@nl
P2093
P2860
P1476
Effects of serum calcium, phos ...... hemodialysis patients in Japan
@en
P2093
Junichiro Kazama
Keitaro Yokoyama
Kunitoshi Iseki
Patient Registration Committee of the Japanese Society for Dialysis Therapy, Tokyo, Japan
Shigeru Nakai
Takashi Akiba
Yoshiharu Tsubakihara
Yoshihiro Tominaga
P2860
P356
10.1111/J.1744-9987.2007.00540.X
P577
2008-02-01T00:00:00Z